<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Definitions</p><p class="Section" id="412370"><strong><a class="sectionLabel" id="s-21.02"><span class="sectionLabel">21.02</span></a></strong> The definitions in this section apply in this section and in sections 21.03 to 21.19.</p><dl class="Definition"><dt id="412372"><span class="DefinedTerm"><dfn>authorization</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>authorization</dfn></span> means an authorization granted under subsection 21.04(1), and includes an authorization renewed under subsection 21.12(1). (<span class="DefinedTermLink" lang="fr">autorisation</span>)</p></dd><dt id="412373"><span class="DefinedTerm"><dfn>General Council</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>General Council</dfn></span> means the General Council of the WTO established by paragraph 2 of Article IV of the Agreement Establishing the World Trade Organization, signed at Marrakesh on April 15, 1994. (<span class="DefinedTermLink" lang="fr">Conseil général</span>)</p></dd><dt id="412374"><span class="DefinedTerm"><dfn>General Council Decision</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>General Council Decision</dfn></span> means the decision of the General Council of August 30, 2003 respecting Article 31 of the TRIPS Agreement, including the interpretation of that decision in the General Council Chairperson’s statement of that date. (<span class="DefinedTermLink" lang="fr">décision du Conseil général</span>)</p></dd><dt id="412375"><span class="DefinedTerm"><dfn>patented product</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>patented product</dfn></span> means a product the making, constructing, using or selling of which in Canada would infringe a patent in the absence of the consent of the patentee. (<span class="DefinedTermLink" lang="fr">produit breveté</span>)</p></dd><dt id="412376"><span class="DefinedTerm"><dfn>pharmaceutical product</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>pharmaceutical product</dfn></span> means any patented product listed in Schedule 1 in, if applicable, the dosage form, the strength and the route of administration specified in that Schedule in relation to the product. (<span class="DefinedTermLink" lang="fr">produit pharmaceutique</span>)</p></dd><dt id="412377"><span class="DefinedTerm"><dfn>TRIPS Agreement</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>TRIPS Agreement</dfn></span> means the Agreement on Trade-Related Aspects of Intellectual Property Rights, being Annex 1C of the Agreement Establishing the World Trade Organization, signed at Marrakesh on April 15, 1994. (<span class="DefinedTermLink" lang="fr">Accord sur les ADPIC</span>)</p></dd><dt id="412378"><span class="DefinedTerm"><dfn>TRIPS Council</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>TRIPS Council</dfn></span> means the council referred to in the TRIPS Agreement. (<span class="DefinedTermLink" lang="fr">Conseil des ADPIC</span>)</p></dd><dt id="412379"><span class="DefinedTerm"><dfn>WTO</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>WTO</dfn></span> means the World Trade Organization established by Article I of the Agreement Establishing the World Trade Organization, signed at Marrakesh on April 15, 1994. (<span class="DefinedTermLink" lang="fr">OMC</span>)</p></dd></dl><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">2004, c. 23, s. 1</li></ul></div>
